Tongai G Maponga
Overview
Explore the profile of Tongai G Maponga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Goussard P, Schubert P, Parker N, Myburgh C, Rabie H, van der Zalm M, et al.
Pediatr Pulmonol
. 2022 Mar;
57(5):1363-1365.
PMID: 35243813
No abstract available.
12.
Mokaya J, Maponga T, McNaughton A, Van Schalkwyk M, Hugo S, Singer J, et al.
J Clin Virol
. 2020 Jul;
129:104548.
PMID: 32663786
Introduction: Tenofovir disoproxil fumarate (TDF) is widely recommended for treatment of chronic hepatitis B virus (HBV) infection because it is safe, affordable and has a high genetic barrier to resistance....
13.
Maponga T, Lopes T, Cable R, Pistorius C, Preiser W, Andersson M
Vox Sang
. 2020 Jun;
115(8):695-702.
PMID: 32597542
Background: Transfusion-transmitted hepatitis E virus (HEV) infection is a potential risk to recipients of blood transfusions. Infection with HEV poses a high risk to immunocompromised recipients with an increased likelihood...
14.
Geffert K, Maponga T, Henerico S, Preiser W, Mongella S, Stich A, et al.
BMC Infect Dis
. 2020 Jun;
20(1):395.
PMID: 32503443
Background: Tanzania has a high prevalence (7.17%) of chronic hepatitis B infection. Mother to Child transmission is very common, resulting in high rate of chronic infections. Currently, there is no...
15.
Maponga T, McNaughton A, Van Schalkwyk M, Hugo S, Nwankwo C, Taljaard J, et al.
J Infect
. 2020 May;
81(1):121-130.
PMID: 32360882
Objectives: Prompted by international targets for elimination of hepatitis B virus (HBV), we set out to characterise individuals with HBV monoinfection vs. those coinfected with HBV/HIV, to evaluate the impact...
16.
McNaughton A, Lourenco J, Bester P, Mokaya J, Lumley S, Obolski U, et al.
PLoS Med
. 2020 Apr;
17(4):e1003068.
PMID: 32315297
Background: International Sustainable Development Goals (SDGs) for elimination of hepatitis B virus (HBV) infection set ambitious targets for 2030. In African populations, infant immunisation has been fundamental to reducing incident...
17.
Maponga T, Matteau Matsha R, Morin S, Scheibe A, Swan T, Andrieux-Meyer I, et al.
Hepatol Med Policy
. 2018 Oct;
2:8.
PMID: 30288321
The International AIDS Society convened the 3rd International HIV/Viral Hepatitis Co-Infection Meeting on 17 July 2016 as part of the pre-conference program preceding the 21st International AIDS Conference held in...
18.
Andersson M, Preiser W, Maponga T, Heys I, Taljaard J, Van Rensburg C, et al.
AIDS
. 2013 Jan;
27(3):487-9.
PMID: 23291543
No abstract available.
19.
Andersson M, Maponga T, Ijaz S, Theron G, Preiser W, Tedder R
J Acquir Immune Defic Syndr
. 2012 Jul;
60(4):e111-2.
PMID: 22772348
No abstract available.